Recent FDA Drug Approvals
The Food and Drug Administration (FDA) recently approved the following oncology drugs:
- FDA Approves Cemiplimab-rwlc in Combination With Platinum-based Chemotherapy For Non-small Cell Lung Cancer
- FDA Approves Brentuximab Vedotin in Combination With Chemotherapy For Pediatric Patients With Classical Hodgkin Lymphoma
- FDA Approves Tremelimumab In Combination With Durvalumab and Platinum-Based Chemotherapy For Metastatic Non-Small Cell Lung Cancer
- FDA Grants Accelerated Approval to Mirvetuximab Soravtansine-Gynx For Frα Positive, Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
Please visit the FDA Hematology/Oncology (Cancer) Approvals & Safety Notifications webpage for a list of current and past approvals.